Skip to search formSkip to main contentSkip to account menu

AD 810

Known as: AD-810 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

zonisamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1996
Review
1996
[Research and development of zonisamide, a new type of antiepileptic drug].
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide, AD-810) is a broad spectrum antiepileptic drug which has been launched in… 
1990
1990
Effect of zonisamide on serum immunoglobulins.
Zonisamide (AD-810) was additionally administered to 19 patients with refractory epilepsy who had been receiving multiple… 
1989
1989
小児難治性てんかんに対するZonisamide (AD-810) 投与の試み
新しい抗てんかん薬Zonisamide (AD-810) を, 平均年齢13歳2カ月の小児を中心とした難治性てんかん患者36例に投与し, その有用性について検討した。その結果, 著効3例, 有効5例の合計8例 (22… 
1988
1988
小児てんかんに対するzonisamide (AD-810) の治療効果と血中濃度
1987
1987
Increasing anticonvulsant effect of AD-810 (zonisamide) in aging BDF1 mice.
1987
1987
新しい抗てんかん薬 zonisamide (AD-810) の難治性てんかんに対する使用経験.
1986
1986
小児てんかんに対するzonisamide (AD-810) の治療効果
1985
1985
Differential antagonism of denzimol to various components of metrazol-induced seizures in rats and mice.
1980
1980
Differential antagonisms of anticonvulsants to various components of maximal seizures induced by electroshock or pentylenetetrazol in mice.
Effects of antiepileptic drugs on various components (TF: tonic extension of forelimb, TH: tonic extension of hindlimb and CL… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)